Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael G Jobling

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Microbial Drug Resistance (Larchmont, N.Y.)|August 16, 2022
After Verification: Analysis of Kim and Ko's Response to M. Jobling (Re: Trust But Verify; DOI: 10.1089/mdr.2018.0426)Michael G Jobling
Biotechniques|June 13, 2020
Plasmid multimer status and not DNA topology likely affects luciferase assay reproducibilityMichael G Jobling
Antimicrobial Agents and Chemotherapy|July 21, 2022
The Retraction of a Plasmid-Phage Chimera Genome Assembly Study Leaves Serious Issues Unaddressed-Essentially, Nolo ContendereMichael G Jobling
Msphere|April 27, 2018
Ectopic Expression of the <i>ydaS</i> and <i>ydaT</i> Genes of the Cryptic Prophage Rac of <i>Escherichia coli</i> K-12 May Be Toxic but Do They Really Encode Toxins?: a Case for Using Genetic Context To Understand FunctionMichael G Jobling
Open Forum Infectious Diseases|November 2, 2020
Novel Type II Heat-Labile Enterotoxin Produced by Human Disease Outbreak Isolates of <i>Escherichia coli</i> Is a Member of the LT-IIa Family and Should Not Form a New Group: Clarification of Nomenclature and PrecedentMichael G Jobling
Pathogens and Disease|January 13, 2016
The chromosomal nature of LT-II enterotoxins solved: a lambdoid prophage encodes both LT-II and one of two novel pertussis-toxin-like toxin family members in type II enterotoxigenic Escherichia coliMichael G Jobling
Mbio|May 5, 2021
Lysogeny of Escherichia coli by the Obligately Lytic Bacteriophage T1: Not ProvenMichael G Jobling
International Journal of Antimicrobial Agents|December 30, 2018
If extraordinary data are not first corroborated, we risk being led astray: Occam's razor does not support the existence of plasmid-prophage chimeras. Comment on 'Effects of cryptic prophage regions in a plasmid carrying a carbapenemase gene on survival against antibiotic stress'Michael G Jobling
International Journal of Antimicrobial Agents|February 2, 2021
Escherichia coli prophage sequences are not present in a carbapenemase plasmid from Klebsiella. Reply to Authors' response to Letter to the Editor: If extraordinary data are not first corroborated, we risk being led astray: Occam's razor does not support the existence of plasmid-prophage chimeras. Comment on 'Effects of cryptic prophage regions in a plasmid carrying a carbapenemase gene on survival against antibiotic stress'Michael G Jobling
Microbial Drug Resistance (Larchmont, N.Y.)|July 26, 2019
Trust but Verify: Uncorroborated Assemblies of Plasmid Genomes from Next-Generation Sequencing Data Are Likely Spurious <i>Comment on</i> "Diverse Plasmids Harboring <i>bla</i><sub>CTX-M-15</sub> in <i>Klebsiella pneumoniae</i> ST11 Isolates from Several Asian Countries," by So Yeon Kim and Kwan Soo Ko (Microb. Drug Resist. 2019; 25(2):227-232; DOI: 10.1089/mdr.2018.0020)Michael G Jobling
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Microbial Drug Resistance (Larchmont, N.Y.)|August 16, 2022
After Verification: Analysis of Kim and Ko's Response to M. Jobling (Re: Trust But Verify; DOI: 10.1089/mdr.2018.0426)Michael G Jobling
Biotechniques|June 13, 2020
Plasmid multimer status and not DNA topology likely affects luciferase assay reproducibilityMichael G Jobling
Antimicrobial Agents and Chemotherapy|July 21, 2022
The Retraction of a Plasmid-Phage Chimera Genome Assembly Study Leaves Serious Issues Unaddressed-Essentially, Nolo ContendereMichael G Jobling
Msphere|April 27, 2018
Ectopic Expression of the <i>ydaS</i> and <i>ydaT</i> Genes of the Cryptic Prophage Rac of <i>Escherichia coli</i> K-12 May Be Toxic but Do They Really Encode Toxins?: a Case for Using Genetic Context To Understand FunctionMichael G Jobling
Open Forum Infectious Diseases|November 2, 2020
Novel Type II Heat-Labile Enterotoxin Produced by Human Disease Outbreak Isolates of <i>Escherichia coli</i> Is a Member of the LT-IIa Family and Should Not Form a New Group: Clarification of Nomenclature and PrecedentMichael G Jobling
Pathogens and Disease|January 13, 2016
The chromosomal nature of LT-II enterotoxins solved: a lambdoid prophage encodes both LT-II and one of two novel pertussis-toxin-like toxin family members in type II enterotoxigenic Escherichia coliMichael G Jobling
Mbio|May 5, 2021
Lysogeny of Escherichia coli by the Obligately Lytic Bacteriophage T1: Not ProvenMichael G Jobling
International Journal of Antimicrobial Agents|December 30, 2018
If extraordinary data are not first corroborated, we risk being led astray: Occam's razor does not support the existence of plasmid-prophage chimeras. Comment on 'Effects of cryptic prophage regions in a plasmid carrying a carbapenemase gene on survival against antibiotic stress'Michael G Jobling
International Journal of Antimicrobial Agents|February 2, 2021
Escherichia coli prophage sequences are not present in a carbapenemase plasmid from Klebsiella. Reply to Authors' response to Letter to the Editor: If extraordinary data are not first corroborated, we risk being led astray: Occam's razor does not support the existence of plasmid-prophage chimeras. Comment on 'Effects of cryptic prophage regions in a plasmid carrying a carbapenemase gene on survival against antibiotic stress'Michael G Jobling
Microbial Drug Resistance (Larchmont, N.Y.)|July 26, 2019
Trust but Verify: Uncorroborated Assemblies of Plasmid Genomes from Next-Generation Sequencing Data Are Likely Spurious <i>Comment on</i> "Diverse Plasmids Harboring <i>bla</i><sub>CTX-M-15</sub> in <i>Klebsiella pneumoniae</i> ST11 Isolates from Several Asian Countries," by So Yeon Kim and Kwan Soo Ko (Microb. Drug Resist. 2019; 25(2):227-232; DOI: 10.1089/mdr.2018.0020)Michael G Jobling
Pageof 4